315 related articles for article (PubMed ID: 23658244)
1. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
[TBL] [Abstract][Full Text] [Related]
2. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
[No Abstract] [Full Text] [Related]
3. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
Chung T; Na J; Kim YI; Chang DY; Kim YI; Kim H; Moon HE; Kang KW; Lee DS; Chung JK; Kim SS; Suh-Kim H; Paek SH; Youn H
Theranostics; 2016; 6(10):1477-90. PubMed ID: 27446484
[TBL] [Abstract][Full Text] [Related]
8. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
9. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
[TBL] [Abstract][Full Text] [Related]
10. Double suicide gene therapy using human neural stem cells against glioblastoma: double safety measures.
Lee JY; Lee DH; Kim HA; Choi SA; Lee HJ; Park CK; Phi JH; Wang KC; Kim SU; Kim SK
J Neurooncol; 2014 Jan; 116(1):49-57. PubMed ID: 24113876
[TBL] [Abstract][Full Text] [Related]
11. Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.
Yi BR; Hwang KA; Kim YB; Kim SU; Choi KC
Int J Mol Sci; 2012 Sep; 13(10):12519-32. PubMed ID: 23202910
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma.
Gutova M; Flores L; Adhikarla V; Tsaturyan L; Tirughana R; Aramburo S; Metz M; Gonzaga J; Annala A; Synold TW; Portnow J; Rockne RC; Aboody KS
Front Oncol; 2019; 9():68. PubMed ID: 30838174
[TBL] [Abstract][Full Text] [Related]
13. Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line.
Khosh N; Brown CE; Aboody KS; Barish ME
PLoS One; 2012; 7(12):e51859. PubMed ID: 23240066
[TBL] [Abstract][Full Text] [Related]
14. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
15. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models.
Yi BR; Park MA; Lee HR; Kang NH; Choi KJ; Kim SU; Choi KC
Mol Oncol; 2013 Jun; 7(3):543-54. PubMed ID: 23403306
[TBL] [Abstract][Full Text] [Related]
18. The growth of K562 human leukemia cells was inhibited by therapeutic neural stem cells in cellular and xenograft mouse models.
Park GT; Heo JR; Kim SU; Choi KC
Cytotherapy; 2018 Sep; 20(9):1191-1201. PubMed ID: 30078654
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients.
Portnow J; Badie B; Suzette Blanchard M; Kilpatrick J; Tirughana R; Metz M; Mi S; Tran V; Ressler J; D'Apuzzo M; Aboody KS; Synold TW
Cancer Gene Ther; 2021 Apr; 28(3-4):294-306. PubMed ID: 32895489
[TBL] [Abstract][Full Text] [Related]
20. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth.
Kim KY; Kim SU; Leung PC; Jeung EB; Choi KC
Cancer Sci; 2010 Apr; 101(4):955-62. PubMed ID: 20704576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
